Singapore, Oct. 23 -- South Korea-based SK Biopharmaceuticals has announced the establishment of Mentis Care, Inc., a joint venture (JV) with a leading Brazil-based pharmaceutical company, Eurofarma, with presence in 24 countries, including North America, Latin America and Africa, to commercialise an artificial intelligence (AI)-based epilepsy management platform.

Since 2018, SK Biopharmaceuticals has built its proprietary expertise in AI-driven electroencephalography (EEG) and wearable device technologies with seizure detection and real-time monitoring. Mentis Care will leverage these technologies to develop a comprehensive digital platform that combines real-time seizure detection and prediction algorithms with clinical decision suppor...